Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Touchstone Innovations (formerly Imperial Innovations)

August 4, 2015
Innovations leads £2.5m funding round in Oxford Biotrans
Innovations has now committed £1.25 million to the Series A round alongside existing investors IP Group and the University of Oxford, with new investors Oxford Innovations and Technology EIS fund and De Monchy Aromatics also participating. More

June 30, 2015
Innovations leads £3 million investment in Abingdon Health
Imperial Innovations Group plc (AIM: IVO; ‘the Group’, ‘Innovations’) has led a £3.0 million investment in portfolio company Abingdon Health Ltd (‘the Company’) alongside existing investors. More

June 3, 2015
Auspherix Raises £6Million to Progress its Novel Antibiotics and Establishes UK Operations
In the race to develop new antibiotics with completely new modes of action that might address the growing threat posed by antimicrobial resistance, Auspherix Limited (UK), an early stage anti-infectives company originated in Sydney Australia, has raised £6 million in a Series A venture financing. More

May 19, 2015
Innovations leads £25m Series C funding round in PsiOxus
Imperial Innovations Group plc (AIM: IVO; ‘the Group’, ‘Innovations’) has led a £25 million Series C funding round in portfolio company PsiOxus Therapeutics which is developing innovative oncolytic immuno-oncology treatments for cancer. More

April 27, 2015
Autifony Therapeutics recruits first patient into Phase IIa trial for age related hearing loss
Imperial Innovations Group plc (AIM: IVO, 'Innovations', “the Group”) is pleased to note that portfolio company Autifony Therapeutics (“Autifony” or “the Company”) has today announced that it has recruited the first subject in a Phase IIa study for treatment of age-related hearing loss. More

January 15, 2015
Imperial Innovations leads £18 million Series B funding round in Veryan
Imperial Innovations has led a £18m series B funding round in Veryan Holdings Limited alongside co-investors Invesco Asset Management, Seroba Kernel and Seven Mile. More

October 1, 2013
Circassia’s grass allergy treatment achieves significant symptom reduction during hay fever season
Circassia, the specialty biopharmaceutical company focused on allergy, has achieved successful results from a large phase II clinical study of its grass allergy treatment. More

July 2, 2013
£30m, 12-year loan to Imperial Innovations from European Investment Bank for healthcare investment
Imperial Innovations Group plc has obtained a loan for a period of 12 years from the European Investment Bank (EIB) to invest in the biotech and therapeutics sectors. More

June 25, 2013
Imperial Innovations Investment in PsychologyOnline
Imperial Innovations Group a leading technology commercialisation and investment company, has invested £0.5m in new portfolio company, PsychologyOnline, a Cambridge-based provider of clinically-proven online cognitive behavioural therapy (CBT) for the treatment of depression. More

February 25, 2013
Circassia’s cat allergy treatment shows sustained symptom improvement
Circassia, the speciality biopharmaceutical company focused on allergy, has seen strong results from its follow up phase II clinical trial. More

November 16, 2012
Veryan receives CE Mark approval for BioMimics 3D™ Stent
Imperial Innovations Group plc, a leading technology commercialisation and investment group, announces that portfolio company Veryan, a vascular disease specialist, has received CE Mark approval for the BioMimics 3D Stent. More

December 7, 2009
Kurma Biofund, a recently launched fund, announces a new relationship with Imperial Innovations
Kurma Biofund, a recently launched life science fund, announces a new relationship with Imperial Innovations plc (London). More

September 1, 2009
Imperial Innovations leads £2 million funding round in Molecular Vision
Imperial Innovations Group, a technology commercialisation and investment company, has led a £2 million funding round in Molecular Vision, a developer of quantitative point-of-care diagnostic devices. More

May 28, 2009
Technip expands its technological leadership in ethylene by acquiring IP rights from HeliSwirl
Technip expands its technological leadership in ethylene by acquiring intellectual property rights from HeliSwirl. More

April 2, 2009
Imperial Innovations invests £2.5m in portfolio company Veryan
Imperial Innovations, a leading technology commercialisation and investment company, has invested £2.5 million in a further funding round for portfolio company Veryan Holdings Limited. More

September 17, 2008
Imperial Innovations announces senior appointments
Imperial Innovations Group plc (AIM: IVO), a leading technology transfer and commercialisation company, today announces a series of senior appointments across the company and its portfolio of technology businesses. More

July 2, 2008
The Recycling Commercialisation Centre signs up Recyclatech
Imperial Innovations Group announces that the Recycling Commercialisation Centre, managed by Imperial Innovations on behalf of WRAP (Waste & Resources Action Programme), will provide incubation and support services to Recyclatech, a Scottish company focused on the recycling of rubber tyres. More

May 30, 2008
Imperial Innovations invests £175,000 in Evince Technology
Imperial Innovations Group plc, today announces that the Low Carbon Seed Fund, a £2 million fund established by The Shell Foundation, The Carbon Trust and Imperial Innovations has invested £175,000 in Evince Technology Ltd. More

February 1, 2008
Imperial Innovations signs contract with NPL
Imperial Innovations Group plc, today announces that it has been awarded a contract by the National Physical Laboratory (NPL), for the provision of commercialisation services based on the extensive research activities undertaken at NPL. More

January 29, 2008
Circassia raises £11 million in oversubscribed second funding round
Imperial Innovations Group plc, today announces the investment of £11 million in biotechnology company Circassia Holdings Limited, a company developing medicines designed to control immune system responses. More

January 14, 2008
Imperial Innovations - Commercialisation deals signed
Imperial Innovations Group today announces that it has signed commercialisation contracts with a number of healthcare organisations. More

November 22, 2007
Imperial Innovations raises £1.5m to seed Indian operation
Imperial Innovations Group plc, today announces that £1.5 million of seed funding has been raised for i2india Holdings Limited, a technology commercialisation and investment company focused on creating commercial value from intellectual property developed in India. More

October 1, 2007
Imperial Innovations / sale of Stoneglass Building Products
Imperial Innovations Group, today announces the first exit from the Recycling Commercialisation Centre, a facility managed by Imperial Innovations and funded by WRAP (Waste & Resources Action Programme). More

September 24, 2007
Imperial Innovations notes the success of its portfolio companies at The Engineer Awards 2007
Imperial Innovations Group plc is pleased to note the success of the following Imperial Innovations companies, technologies and entrepreneurs at a ceremony held on Friday 21 September to celebrate The Engineer Technology & Innovation Awards 2007. More

July 30, 2007
Imperial Innovations invests in Acrobot Ltd
Imperial Innovations Group, the technology commercialisation and investment company today announces that it has closed an investment in The Acrobot Company Limited, a company focusing on computer assistance for orthopaedic surgery. More

June 8, 2007
Imperial Innovations Spinout wins MacRobert Award
Process Systems Enterprise (PSE) wins MacRobert Award More

March 16, 2007
Imperial Innovations signs Stoneglass Building Products to the Recycling Commercialisation Center
Imperial Innovations signs Stoneglass Building Products Limited to the Recycling Commercialisation Centre More

March 12, 2007
Imperial Innovations technology company sells first products
Imperial Innovations Group, the technology commercialisation and investment company, announces that ionscope Ltd, a microscope technology company formed by Imperial Innovations and based on research carried out at Imperial College London and the University of Cambridge has received first orders for its products More

February 26, 2007
Imperial Innovations and Imperial College team win Brian Mercer Award for Innovation 2007
Imperial Innovations Group, the technology commercialisation and investment company, announces that a multidisciplinary team from Imperial College London, Molecular Vision Ltd and Imperial Innovations has won the £250,000 Royal Society Brian Mercer Award for Innovation 2007, to develop two innovative nanotechnology concepts through to commercial exploitation.
More

February 13, 2007
Imperial Innovations signs Rubber-Regen LLP to its recycling commercialisation centre
Recycling Commercialisation Centre signs up rubber recycling company More

February 1, 2007
Imperial Innovations invests in ATT
Investment in Advanced Tissue Therapies Ltd
Appointment of Innovations board director to the board of Advanced Tissue Therapies More

November 27, 2006
Imperial Innovations wins renewed Carbon Trust incubation mandate
Imperial Innovations Group plc today announces the renewal of its incubation contract with the Carbon Trust. More

October 18, 2006
New Low Carbon Seed Fund Launched
Imperial Innovations Group, one of the leading technology transfer and commercialisation companies in the UK, announces a new £2 million fund, The Low Carbon Seed Fund, that has been established through £1 million from Imperial Innovations that was funded by a grant from Shell Foundation and through £1 million from The Carbon Trust. More

October 9, 2006
Establishment of The Consensus Imperial Innovations Commercialisation Centre
Consensus and Imperial Innovations in partnership More

May 10, 2006
Imperial Innovations spin-outs win grants for R&D from the London Development Agency
Imperial Innovations today announced that six of the companies in its portfolio have been awarded Research and Development Grants worth nearly £700,000 in total. More

February 27, 2006
Imperial Innovations to take stake in ParOS Plc
Imperial Innovations, the technology commercialisation company of Imperial College London, announced that spin-out company Parametric Optimization Solutions (ParOS) has entered into a conditional agreement to be acquired by Oak Prospects, an investment company currently admitted to trading on OFEX. More

Data


25,983
Tech investments
From our Online Data Service
16,806
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Aug 12€2.4MBusiness applications
Aug 12€0.7MMedical devices
Aug 12N/AMedical devices
Aug 9€7.0MSoftware development
Aug 9€0.3MeLearning
Aug 9N/AOther Biotechnology & Healthcare
Aug 7€3.8MDiagnostics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.